Investigating IBM and VCP Patient Characteristics in Rural and Urban areas using the AllStripes Research Real-World Data Platform
Patients with rare diseases face multiple barriers to care, including availability of developed therapies and distance to clinical specialists and clinical trials. Here, we use our real-world data (RWD) platform to investigate the distribution of patients in the United States across rural and urban areas with inclusion body myositis (IBM) and valosin-containing protein (VCP) disease. This poster was presented at the Global Genes RARE Drug Development Symposium in June 2021.
Treatment Patterns for Depression and Anxiety Among Patients with Progressive Supranuclear Palsy (PSP)